Interleukin-2 Treatment for Wiskott-Aldrich Syndrome (WAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00774358
Recruitment Status : Completed
First Posted : October 17, 2008
Last Update Posted : August 16, 2017
Texas Children's Hospital
Information provided by (Responsible Party):
Soma Jyonouchi, Children's Hospital of Philadelphia

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2016
  Study Completion Date : September 2016